Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2018
Office of the Director, NIH - Additional Awards Eligible for PA-18-586 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Office of the Director, NIH - Notice of Correction to Key Dates for PAR-17-450 "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)"
Office of the Director, NIH - Transition from Inclusion Management System to New Human Subjects System (HSS) as of June 9, 2018
Office of the Director, NIH - Notice of Change in Data Table Instructions for the PAR-18-746 NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
National Institute on Drug Abuse - Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-010 - Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations (U01)
Food and Drug Administration - Notice of Application Form Issue for RFA-HD-19-017, "National Centers for Translational Research in Reproduction and Infertility (P50)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change to IND/IDE Authorization Timing Requirement for PAR-18-406 "Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)"
National Heart, Lung, and Blood Institute - Notice of Change to IND/IDE Authorization Timing Requirement for PAR-18-407 "Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)"
National Heart, Lung, and Blood Institute - Notice of NIMHD's Interest in the Health of Puerto Rican and US Virgin Island Residents Migrating to the US Mainland after Hurricanes Irma and Maria
National Institute on Minority Health and Health Disparities - Notice of Expiration of PA-18-473 "Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)"
National Institute of Nursing Research - National Center for Advancing Translational Sciences (NCATS) Policy for Support of Phase III Clinical Trial Activities for a Rare Disease or Condition
National Center for Advancing Translational Sciences
Requests for Applications
- Investigation of the Transmission of Kaposi Sarcoma-associated Herpesvirus (KSHV)(R01 Clinical Trial Optional)
- Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed)
National Cancer Institute
- Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Research Program Award (R35 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Program Announcements
- Collaborative Activities to Expedite Environmental Health Science Research, Translation, and Community Engagement Across EHS Core Centers (Admin Supp - Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)
National Institute on Drug Abuse
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
- Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
- Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
National Institute of Nursing Research
- Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional)
National Institute on Drug Abuse
- NIOSH Occupational Safety and Health Research (R01)
National Institute for Occupational Safety and Health
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Novel Genomic Technology Development (R01 Clinical Trial Not Allowed)
- Novel Genomic Technology Development (R21 Clinical Trial Not Allowed)
- Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed)
National Human Genome Research Institute
- Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)
National Institute of Allergy and Infectious Diseases
- NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu